What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.55%Below 5Y avg (3.09%)
Annual Rate
KRW 3000.00Paid semi-annual
Payout Ratio
14.6%Sustainable
Payback Period
73.2 yr
Last Ex-Dividend
Aug 14, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
32.18TKRW
22.78B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
128.55TKRW
91.02B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
2.04%
vs Conglomerates peers
Updated Aug 19, 2026
Beta
1.61x
vs all stocks
Updated Aug 19, 2026
52-Week Change
200.27%
vs all stocks
Updated Aug 19, 2026
Forward Annual Dividend Yield
0.55%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
32.18TKRW
22.78B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
148.87TKRW
105.40B · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
4.28x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Sales (TTM)
0.2503x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Book (MRQ)
0.3062x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to Revenue
1.16x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to EBITDA
11.85x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 4.73×.Updated Aug 19, 2026
Gross Margin
15.50%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.1%.Updated Aug 19, 2026
Profit Margin
2.04%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Margin
9.78%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Assets (TTM)
1.24%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Equity (TTM)
11.91%
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
128.55TKRW
91.02B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
2.36MKRWUpdated Aug 19, 2026
Quarterly Revenue Growth
18.90%
vs Conglomerates peers
Updated Aug 19, 2026
Gross Profit (TTM)
12.98TKRW
9.19B · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
31.50TKRW
22.30B · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
3.26TKRW
2.31B · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
43.90%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
6.97TKRW
4.93B · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
4.27TKRW
3.02B · vs all stocks (USD)
Updated Aug 19, 2026
Forward Annual Dividend Rate
3.00KKRWUpdated Aug 19, 2026
Forward Annual Dividend Yield
0.55%
vs all stocks
Updated Aug 19, 2026
Trailing Annual Dividend Rate
8.00KKRWUpdated Aug 19, 2026
Trailing Annual Dividend Yield
1.47%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
3.09%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
14.60%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -32.84%.Updated Aug 19, 2026
Minority Interest (Equity)
60.50TKRWFY2025 · Dec 31, 2025
Revenue
122.70TKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
113.12TKRWFY2025 · Dec 31, 2025
Gross Profit
9.59TKRWFY2025 · Dec 31, 2025
Operating Income
1.82TKRW
1.29B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
2.64TKRWFY2025 · Dec 31, 2025
Income Tax Expense
281.17BKRWFY2025 · Dec 31, 2025
Net Income
3.56TKRWFY2025 · Dec 31, 2025
EBIT
5.71TKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
21.54TKRWFY2025 · Dec 31, 2025
Research & Development
620.19BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
3.30TKRWFY2025 · Dec 31, 2025
Other Operating Expenses
481.66BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
865.71BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.08TKRWFY2025 · Dec 31, 2025
Net Income from Continuing Operations
3.56TKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.96TKRWFY2025 · Dec 31, 2025
Operating Cash Flow
5.58TKRWFY2025 · Dec 31, 2025
Free Cash Flow
-2.89TKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
25.21TKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
3.56TKRWFY2025 · Dec 31, 2025
Other Non-cash Items
2.91TKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-386.29BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-499.48BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-8.47TKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-397.95BKRWFY2025 · Dec 31, 2025
Net Acquisitions
4.96TKRWFY2025 · Dec 31, 2025
Purchase of Investments
-1.44TKRWFY2025 · Dec 31, 2025
Sale of Investments
3.13TKRWFY2025 · Dec 31, 2025
Other Investing Activity
1.93TKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
118.97BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
21.89TKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-25.11TKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-7.81TKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-1.54TKRWFY2025 · Dec 31, 2025
Other Financing Charges
709.43BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
-11.86TKRWFY2025 · Dec 31, 2025
Shares Outstanding
54.52MSharesUpdated Aug 19, 2026
Float Shares
36.25MSharesUpdated Aug 19, 2026
% Held by Insiders
25.40%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
22.20%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
27.69TKRW
19.61B · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
507.91KKRWUpdated Aug 19, 2026
Total Debt (MRQ)
77.20TKRW
54.66B · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.7956x
vs Conglomerates peers
Updated Aug 19, 2026
Current Ratio (MRQ)
0.9630x
vs Conglomerates peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
1.78MKRWUpdated Aug 19, 2026
Total Assets
213.52TKRW
151.18B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
71.68TKRWFY2025 · Dec 31, 2025
Total Liabilities
127.83TKRWFY2025 · Dec 31, 2025
Total Non-current Assets
141.84TKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
60.70TKRWFY2025 · Dec 31, 2025
Total Current Liabilities
67.13TKRWFY2025 · Dec 31, 2025
Cash Equivalents
25.21TKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
25.21TKRWFY2025 · Dec 31, 2025
Other Short-term Investments
3.50TKRWFY2025 · Dec 31, 2025
Accounts Receivable
13.13TKRWFY2025 · Dec 31, 2025
Inventory
13.64TKRWFY2025 · Dec 31, 2025
Accounts Payable
13.08TKRWFY2025 · Dec 31, 2025
Short-term Debt
27.79TKRWFY2025 · Dec 31, 2025
Other Current Liabilities
123.53BKRWFY2025 · Dec 31, 2025
Long-term Debt
49.36TKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
737.70BKRWFY2025 · Dec 31, 2025
Common Stock (Book)
16.03BKRWFY2025 · Dec 31, 2025
Retained Earnings
13.01TKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
85.69TKRW
60.67B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
1.95TKRWFY2025 · Dec 31, 2025
52-Week Low
176.90KKRWUpdated Aug 19, 2026
52-Week High
883.00KKRWUpdated Aug 19, 2026
52-Week Change
200.27%
vs all stocks
Updated Aug 19, 2026
Beta
1.61x
vs all stocks
Updated Aug 19, 2026
50-Day MA
622.87KKRWUpdated Aug 19, 2026
200-Day MA
417.10KKRWUpdated Aug 19, 2026
Avg 10-Day Volume
159.80KSharesUpdated Aug 19, 2026
Avg 30-Day Volume
226.83KSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-24.36KKRWUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.31×, lower than 95% of its Conglomerates peers (median 1.62×)Notable